Welcome to LookChem.com Sign In|Join Free
  • or
Isoxazolo[4,5-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-, ethyl ester, monohydrochloride is a chemical compound that serves as a crucial intermediate in the synthesis of various pharmaceutical drugs. It is an ethyl ester of a carboxylic acid, which has been converted into a monohydrochloride salt to enhance its stability and solubility in water. Isoxazolo[4,5-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-, ethyl ester, monohydrochloride is widely utilized in organic synthesis and pharmaceutical research, playing a significant role as a building block for the development of new drugs and organic compounds.

912265-91-9

Post Buying Request

912265-91-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

912265-91-9 Usage

Uses

Used in Pharmaceutical Research and Development:
Isoxazolo[4,5-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-, ethyl ester, monohydrochloride is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique chemical structure allows it to be a versatile building block for the development of new medications with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, Isoxazolo[4,5-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-, ethyl ester, monohydrochloride is employed as a valuable precursor for the preparation of a wide range of organic compounds. Its reactivity and functional groups make it suitable for various chemical reactions, enabling the synthesis of complex molecules with diverse applications.
Used in Drug Formulation:
Isoxazolo[4,5-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-, ethyl ester, monohydrochloride is used as a component in drug formulations to improve the solubility, stability, and bioavailability of active pharmaceutical ingredients. Its monohydrochloride salt form enhances its water solubility, making it an ideal candidate for the development of effective drug delivery systems.
Used in Controlled Laboratory Environments:
Due to its potential health hazards, Isoxazolo[4,5-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-, ethyl ester, monohydrochloride is used in controlled laboratory environments where safety protocols and equipment are in place to minimize risks to researchers and the environment. This ensures that the compound can be handled and utilized safely and effectively in the development of new pharmaceuticals and organic compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 912265-91-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,2,2,6 and 5 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 912265-91:
(8*9)+(7*1)+(6*2)+(5*2)+(4*6)+(3*5)+(2*9)+(1*1)=159
159 % 10 = 9
So 912265-91-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O3.ClH/c1-2-13-9(12)8-6-5-10-4-3-7(6)14-11-8;/h10H,2-5H2,1H3;1H

912265-91-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 4,5,6,7-tetrahydro-[1,2]oxazolo[4,5-c]pyridine-3-carboxylate,hydrochloride

1.2 Other means of identification

Product number -
Other names 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-carboxylic acid ethyl ester hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:912265-91-9 SDS

912265-91-9Relevant academic research and scientific papers

BICYCLIC JAK INHIBITORS AND USES THEREOF

-

, (2020/10/20)

Provided herein are compounds of Formulas (I), (II), (III), and (IV) and subformulas thereof, wherein the variables are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I), (II), (III), or (IV) and methods of using the compounds, e.g., in the treatment of immune disorders, inflammatory disorders, and cancer.

SUBSTITUTED 4,5,6,7-TETRAHYDRO-ISOXAZOLO[4,5-C]PYRIDINE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS

-

, (2008/06/13)

The invention relates to substituted 4, 5, 6, 7-tetrahydro-isoxazolo [4, 5-c] pyridine compounds of formula (I), to a method for their production, to medicaments containing said compounds and to the use of said compounds for producing medicaments. It has been found that substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c] pyridine compounds of general formula (I) are suitable for noradrenaline receptor regulation, in particular for inhibiting the noradrenaline (NA) uptake, for 5-HT receptor regulation, in particular for inhibiting the 5-hydroxy-tryptophan (5-HT) uptake and/or for batrachotoxin (BTX) receptor regulation and can thus be used in particular as pharmaceutical active ingredients in medicaments for the prophylaxis and/or treatment of disorders or diseased that are associated with said receptors or processes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 912265-91-9